What does real AI adoption in healthcare look like when you leave the hype behind?
In this Prague Episode, I speak with Lukas Benzel, Managing Director of the Czech Association of Artificial Intelligence, and Pavlina Walter. We cover hospital adoption, the shift from sick care to prevention, the role of AI in clinical trials, Europe’s strategic approach, and why Singapore’s model is significant. Practical playbooks for investors, founders, and operators.
Chapters
00:00 Welcome and context in Prague
00:35 Who is the Czech AI Association and why it matters
02:10 Hype vs value in AI adoption
04:05 Workshops, education, and finding business value
05:10 Sectors with traction: healthcare, education, defense, public sector
06:20 Health tech in Czech hospitals and regulation reality
07:55 Europe, US, and Asia: where to compete
09:10 Singapore lessons and the AI hub model 12:05 Constraints in hospitals: money, people, data readiness
13:00 Beyond radiology: prevention, trials, and operations
15:10 Patient acceptance, trust, and education
18:05 National AI strategy and public sector adoption
20:05 From basic research to new materials and drugs
21:30 AI for SMEs: pick use cases with ROI
23:00 Is AI a bubble. Why the answer is no
24:15 Productivity, new work, and personal tools
28:40 Cybersecurity and responsible use
31:00 Why an AI association, how to join
Subscribe to Clinical Capital Conversations for unfiltered discussions at the crossroads of science and capital. Investors, founders, and operators welcome.